Icon 100 Capsule contains Itraconazole 100 mg, an antifungal agent belonging to the triazole class, indicated for the treatment of various fungal infections. Itraconazole exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is commonly prescribed for systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. Icon 100 Capsule is administered orally and demonstrates good bioavailability when taken with food, enhancing absorption. The dosing regimen varies depending on the type and severity of infection, and treatment duration should be guided by clinical response and mycological outcomes. Caution is advised in patients with hepatic impairment, congestive heart failure, or those receiving concomitant medications metabolized by cytochrome P450 enzymes, due to potential drug interactions and hepatotoxicity risk. Common adverse effects include gastrointestinal disturbances such as nausea, abdominal pain, and diarrhea, as well as headache and dizziness. Liver function tests should be monitored periodically during prolonged therapy. Icon 100 Capsule should be used under medical supervision, ensuring appropriate diagnosis and monitoring to optimize therapeutic efficacy and minimize adverse effects.

Dosage & How to Use